Jingsong Huang

ORCID: 0000-0002-2609-4717
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Pelvic floor disorders treatments
  • Cardiac Ischemia and Reperfusion
  • Cardiac Fibrosis and Remodeling
  • Optical properties and cooling technologies in crystalline materials
  • Glutathione Transferases and Polymorphisms
  • CAR-T cell therapy research
  • Cardiac electrophysiology and arrhythmias
  • Signaling Pathways in Disease
  • Urinary Bladder and Prostate Research
  • Cancer therapeutics and mechanisms
  • Hepatocellular Carcinoma Treatment and Prognosis
  • Immune Cell Function and Interaction
  • Peptidase Inhibition and Analysis
  • Endometrial and Cervical Cancer Treatments
  • Immune cells in cancer
  • Cancer Immunotherapy and Biomarkers

Xiamen University
2021

Guangdong Academy of Medical Sciences
2019-2020

Guangdong Provincial People's Hospital
2019-2020

South China University of Technology
2020

Southern Medical University
2009-2010

Genetically T cells modified with cancer-specific chimeric antigen receptors (CARs) showed great promise in mediate tumor regression, especially patients advanced leukemia. However, the therapeutic effect against solid tumors is not as prominent anticipated to exhibit potent antitumor efficacy. The underlying mechanism maybe attributed inhibitory co-stimulatory pathways such (PD1/PDL1), which provide an escape from immunosurveillance. Therefore, by exchanging transmembrane and cytoplasmic...

10.2147/cmar.s321402 article EN Cancer Management and Research 2021-08-01
Coming Soon ...